This inventor holds 1 USPTO granted patent. Top assignee: Animal Technology Institute. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Innovator Spotlight: Ming-Shing Liu and His Groundbreaking Transgenic Research
Introduction: Ming-Shing Liu, a prominent inventor based in Miaoli Hsien, Taiwan, is recognized for his significant contributions to the field of transgenic technology. His innovative work focuses on creating transgenic pigs, advancing the potential for xenotransplantation to benefit human health.
Latest Patents: Ming-Shing Liu holds a patent titled "Transgenic pigs carrying both hHO-1 and hDAF transgenes for xenotransplantation." This invention details a transgenic animal that incorporates two important human genes – one that encodes a human decay accelerating factor (hDAF) and another that encodes human heme oxygenase-1 (hHO-1). These advancements are essential for developing cells, tissues, or organs suitable for xenotransplantation, addressing critical issues within organ shortage and transplantation rejection.
Career Highlights: Liu is affiliated with the Animal Technology Institute Taiwan, where he leverages his expertise to push the boundaries of genetic engineering. His work at the institute aligns with his passion for improving health outcomes through innovative scientific solutions. The successful patenting of his transgenic pigs marks a significant milestone in his career, showcasing his commitment to impactful research.
Collaborations: At the Animal Technology Institute Taiwan, Liu collaborates with fellow researchers such as Ching-Fu Tu and Chi-Kai Yang. These partnerships foster an environment of innovation and creativity, essential for advancing the field of xenotransplantation and ensuring continued progress in their shared research goals.
Conclusion: Ming-Shing Liu's inventive spirit and dedication to scientific advancement have made him a notable figure in transgenic research. His patent, which introduces vital transgenic pigs for xenotransplantation, holds the promise of revolutionizing how we approach organ donation and transplantation. Liu's collaborations and contributions continue to inspire the field, paving the way for future innovations that can transform healthcare.